Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 636 | 0 | 0 | 0 | 0 |
| Gross Profit | 636 | N/A | N/A | N/A | N/A |
| Operating Expenses | 61,132 | 78,932 | 67,884 | 45,648 | 25,303 |
| Operating Income | -60,496 | -78,932 | -67,884 | -45,648 | -25,303 |
| Interest Expense | 0 | 0 | 0 | 10 | 49 |
| Other Income | 4,960 | 6,409 | 2,305 | 150 | 412 |
| Pre-tax Income | -55,536 | -72,523 | -65,579 | -45,508 | -24,940 |
| Income Tax | N/A | N/A | N/A | 1,505 | -15 |
| Net Income Continuous | -57,775 | -74,564 | -66,654 | -47,013 | -26,447 |
| Net Income | $-57,775 | $-74,564 | $-66,654 | $-47,013 | $-26,447 |
| EPS Basic Total Ops | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 |
| EPS Basic Continuous Ops | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 |
| EPS Diluted Total Ops | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 |
| EPS Diluted Continuous Ops | -1.33 | -1.84 | -2.09 | -1.84 | -1.52 |
| EPS Diluted Before Non-Recurring Items | -1.33 | -1.84 | -2.09 | -1.84 | N/A |
| EBITDA(a) | $-61,977 | $-81,871 | $-68,152 | $-45,539 | $-25,241 |